XFOR icon

X4 Pharmaceuticals

52 hedge funds and large institutions have $40.2M invested in X4 Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 12 increasing their positions, 14 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

less ownership

Funds ownership:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

37% less call options, than puts

Call options by funds: $266K | Put options by funds: $421K

53% less capital invested

Capital invested by funds: $85.7M → $40.2M (-$45.5M)

67% less funds holding in top 10

Funds holding in top 10: 31 (-2)

Holders
52
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$266K
Puts
$421K
Net Calls
Net Calls Change

Top Buyers

1 +$3.74M
2 +$3.62M
3 +$1.76M
4
Axa
Axa
France
+$1.29M
5
Ensign Peak Advisors
Ensign Peak Advisors
Utah
+$339K

Top Sellers

1 -$4.26M
2 -$2.97M
3 -$2.67M
4
SCM
Sio Capital Management
New York
-$1.21M
5
IC
Ikarian Capital
Texas
-$631K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$6.61M
2
$5.19M
3
$3.74M
4
$3.62M
5
$3.35M
6
$3.15M
7
$2.64M
8
$2.14M
9
$1.94M
10
$780K
11
$767K
12
$713K
13
$634K
14
$628K
15
$546K
16
$464K
17
$407K
18
$404K
19
$314K
20
$301K
21
$238K
22
$179K
23
$178K
24
$155K
25
$152K